Does the Gender Difference in Interferon Production Seen in Picornavirus-Infected Spleen Cell Cultures from ICR Swiss Mice Have AnyIn VivoSignificance?-Reference-Cited by-同舟云学术

Does the Gender Difference in Interferon Production Seen in Picornavirus-Infected Spleen Cell Cultures from ICR Swiss Mice Have AnyIn VivoSignificance?

Published:1993-12 Issue:6 Volume:13 Page:387-395
ISSN:0197-8357
Container-title:Journal of Interferon Research
language:en
Short-container-title:Journal of Interferon Research

Author:

CURIEL RAFAEL E.,MILLER MELISSA H.,ISHIKAWA RIKA,THOMAS DONALD C.,BIGLEY NANCY J.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Immunology

Link

http://www.liebertpub.com/doi/pdf/10.1089/jir.1993.13.387

Reference38 articles.

1. Sex-Dependent, Early Cytokine Production by NK-Like Spleen Cells Following Infection with the D Variant of Encephalomyocarditis Virus (EMCV-D)

2. Sex Hormone Modulation of Interferon (IFN) α/β and γ Production by Mouse Spleen Cell Subsets Following Picornavirus Infection

3. Effect of steroid hormones on virus-induced diabetes mellitus

4. Impaired cytokine response in male ICR Swiss mice after infection with D variant of encephalomyocarditis virus

5. AGM1+ spleen cells contain gamma interferon (IFN-gamma) gene transcripts in the early, sex-dependent production of IFN-gamma after picornavirus infection

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disease parameters following ocular herpes simplex virus type 1 infection are similar in male and female BALB/C mice;PLOS ONE;2023-06-15

2. Testosterone Promotes the Intestinal Replication and Dissemination of Coxsackievirus B3 in an Oral Inoculation Mouse Model;Journal of Virology;2022-09-14

3. Testosterone promotes Coxsackievirus B3 pathogenesis in an oral inoculation mouse model;2021-12-08

4. Antagonizing Peroxisome Proliferator-Activated Receptor Activity Selectively Enhances Th1 Immunity in Male Mice;The Journal of Immunology;2015-10-21

5. Hantavirus Pulmonary Syndrome in Argentina, 1995–2008;Emerging Infectious Diseases;2010-12